Welcome to the e-CCO Library!

P0671: Supporting vedolizumab treatment throughout pregnancy: Insights from a population pharmacokinetic model
Year: 2025
Source: ECCO'25
Authors: Duvnjakx7x7x7 Z.(1x7x7x72)*;Steenholdtx7x7x7 C.(3x7x7x74);Skejøx7x7x7 C.(5);Baunwallx7x7x7 S.M.D.(5);Widigsonx7x7x7 E.S.K.(1x7x7x72);Korgaardx7x7x7 J.(5);Klassenx7x7x7 R.A.(6);Bolstadx7x7x7 N.(6);Kjeldsenx7x7x7 J.(4);Poulsenx7x7x7 A.(7x7x7x78);Kievitx7x7x7 L.(9);Larsenx7x7x7 L.(10x7x7x711);Munkholmx7x7x7 P.(12);Svenningsenx7x7x7 L.(13);Haderslevx7x7x7 K.V.(8);Wildtx7x7x7 S.(14x7x7x715);Vindx7x7x7 I.(14);Kelsenx7x7x7 J.(5x7x7x716);Abrantesx7x7x7 J.A.(17);Micheletx7x7x7 R.(1);Huisingax7x7x7 W.(2x7x7x718);Kloftx7x7x7 C.(1x7x7x72);Julsgaardx7x7x7 M.(5x7x7x716);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0672: Comparative Efficacy of Medical Therapies in Reducing the Risk of Post Operative Recurrence in Crohn’s Disease (PORCD): A Systematic Review and Network Meta-analysis
Year: 2025
Source: ECCO'25
Authors: Shehabx7x7x7 M.(1)*;Alrashed x7x7x7 F.(2);Alrashedx7x7x7 O.(3);Alyousefix7x7x7 R.(3);Zoughlamix7x7x7 A.(4);Lakatosx7x7x7 P.L.(5);Siddharth x7x7x7 S.(6);Matthieu x7x7x7 A.(7);Miguelx7x7x7 R.(8);Bessissowx7x7x7 T.(5);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0673: Proactive switching to subcutaneous vedolizumab in Inflammatory bowel disease correlates with raised trough levels and confers a clinical benefit: a real-world experience.
Year: 2025
Source: ECCO'25
Authors: Foudax7x7x7 S.(1)*;Newbyx7x7x7 Y.(1);Zafarx7x7x7 S.(1);Bourix7x7x7 S.(1);Mohamedx7x7x7 Z.(1);Johnstonx7x7x7 E.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0674: Development of a screening tool to address dietary habits in persons with IBD in Germany
Year: 2025
Source: ECCO'25
Authors: Wilkex7x7x7 E.L.(1)*;Wiestlerx7x7x7 M.(2);Middelhoffx7x7x7 M.(3);Schult-Hannemannx7x7x7 D.(3);Knoedlerx7x7x7 L.L.(1);Ebertx7x7x7 M.P.(1);Reindlx7x7x7 W.(1);Thomannx7x7x7 A.K.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0675: Ultrasonographic assessment of response in hospitalized patients with acute severe ulcerative colitis
Year: 2025
Source: ECCO'25
Authors: Arorax7x7x7 U.(1)*;Kandasamyx7x7x7 D.(2);Vermax7x7x7 M.(1);Madanx7x7x7 D.(1);Singhx7x7x7 M.(1);Narangx7x7x7 H.(1);Goyalx7x7x7 M.(1);Mubunnux7x7x7 M.(1);Panwarx7x7x7 R.(3);Dashx7x7x7 N.R.(3);Goyalx7x7x7 A.(2);Sharmax7x7x7 R.(2);Ahujax7x7x7 V.(1);Kediax7x7x7 S.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0676: Inborn Errors of Immunity Associated with Inflammatory Bowel Disease at a Tertiary Care Centre
Year: 2025
Source: ECCO'25
Authors: Albadawix7x7x7 N.(1)*;Almuhayax7x7x7 H.(1);Alrossaisx7x7x7 N.(1);Binzumanx7x7x7 G.(2);Alhaddabx7x7x7 N.(2);Aljefrix7x7x7 N.(3);Alsehaimx7x7x7 K.(3);Alshaikhx7x7x7 A.(2);Alsoqairx7x7x7 S.(4);Arnaoutx7x7x7 R.(3);Alshareefx7x7x7 S.(3);Albawardyx7x7x7 B.(1);Alsohaibanix7x7x7 F.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0677: Population-Based Analysis of 30-Day Postoperative Course in Crohn’s Disease Patients Undergoing Primary Bowel Resection
Year: 2025
Source: ECCO'25
Authors: Poulsenx7x7x7 A.(1)*;Damsgaard Wewerx7x7x7 M.(2x7x7x73);Linx7x7x7 V.A.(4);Rønne Pachlerx7x7x7 F.(5);Verlox7x7x7 K.A.(2);Rasmussenx7x7x7 J.(6);Søe Riis Jespersenx7x7x7 H.(2);Surnechevax7x7x7 E.(7);Christiansenx7x7x7 D.(6);Holm Hansenx7x7x7 E.(8);Møller Nordestgaardx7x7x7 R.L.(2);Aydemirx7x7x7 N.(6);Dige Ovesenx7x7x7 P.(5);Filtenborg Brandtx7x7x7 C.(1);Gögenurx7x7x7 I.(4);Burischx7x7x7 J.(2x7x7x73);Seidelinx7x7x7 J.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0678: Iron deficiencyx7x7x7 with or without anaemiax7x7x7 in Inflammatory Bowel Disease remains an undermanaged issue: Crohn’s Colitis Cure Data Insights Program
Year: 2025
Source: ECCO'25
Authors: Pinnuckx7x7x7 B.(1)*;Sux7x7x7 W.K.(2x7x7x73);Wilsonx7x7x7 W.(4);Pipicellax7x7x7 J.(3x7x7x75x7x7x76);Ngx7x7x7 W.(2x7x7x76);Antoniadesx7x7x7 S.(7);Walkerx7x7x7 G.(8x7x7x79x7x7x710);Forbesx7x7x7 A.(11);Duttx7x7x7 S.(12x7x7x713);Lynchx7x7x7 K.(1x7x7x714);Connorx7x7x7 S.J.(2x7x7x76x7x7x715x7x7x716);Andrewsx7x7x7 J.M.(17x7x7x718);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0679: Therapeutic Drug Monitoring of the Infliximab (anti-TNF) Level with Bedside Kit in Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Gurx7x7x7 M.B.(1)*;Bakkaloglux7x7x7 O.K.(2);Eskazanx7x7x7 T.(3);Akpinarx7x7x7 A.(3);Hatemix7x7x7 A.İ.(3);Erzinx7x7x7 Y.Z.(3);Celikx7x7x7 A.F.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P067: Angiogenic characterisation of Crohn’s disease mesenteric adipose tissue
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Eddama*1, R. Cohen1, M. Rodriguez-Justo2, I. Evans3, L. Shen4, L. Clapp4, M. Loizidou5

Created: Friday, 22 February 2019, 9:49 AM
P067: Fractal analysis of extracellular matrix as a new histological method for observer-independent quantification of intestinal fibrosis in Crohn's Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Weber, M.C.(1)*;Schmidt, K.(1);Buck, A.(1);Kasajima, A.(2);Becker, S.(3);Wilhelm, D.(1);Friess, H.(4);Neumann, P.A.(1);
Created: Friday, 14 July 2023, 10:48 AM
P067: Human colonic subepithelial myofibroblasts from IBD patients demonstrate a differential expression of Th-related cytokine receptors compared with healthy controls
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Bamias4, E. Filidou1, V. Valatas2, I. Drygiannakis2, K. Arvanitidis1, S. Vradelis3, G. Kouklakis*3, G. Kolios1

Created: Friday, 22 February 2019, 9:41 AM
P067: Human intestinal CD103+SIRPα+ conventional dendritic cells from patients with Crohn´s disease prime IL-17+ T-cells.
Year: 2022
Source: ECCO'22
Authors: Bernardo, D.(1,2);Arribas-Rodriguez, E.(1);De Castro, C.G.(1);Fiz-Lopez, A.(1);De Prado, A.(1,3);Fernandez-Salazar, L.(4);Barrio, J.(3);Izquierdo, S.(4);Garcia-Alonso, J.(3);De Andres, B.(5);Garcia-Abril, J.M.(6);Romero, A.(5);Sanchez-Gonzalez, J.(6);Garrote, J.A.(1);Arranz, E.(1);
Created: Friday, 11 February 2022, 3:52 PM
P067: Molecular profiling of early Crohn's disease reveals a prominent role for WNT5A
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Verstockt S.*1, Van der Goten J.2, Vancamelbeke M.2, Verstockt B.2, Van Lommel L.3, Schuit F.3, Rutgeerts P.2, Ferrante M.2, Vermeire S.2, Arijs I.2,4,5, Cleynen I.1

Created: Wednesday, 20 February 2019, 10:36 AM
P067: Proliferating intestinal macrophage populations in human inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. McDonald1*, P. Wright1, C. Bain2, A. Bravo-Blas1, E. Robertson3,4, A. Mowat1, S. Milling1, D. Gaya4

Created: Thursday, 21 February 2019, 9:14 AM
P067: The effect of a probiotic mix on mucosal healing and fibrotic responses in healthy colonic subepithelial myofibroblasts.
Year: 2021
Source: ECCO'21 Virtual
Authors: Tarapatzi, G.(1);Filidou, E.(1);Kandilogiannakis, L.(1);Arvanitidis, K.(1);Vradelis, S.(2);Kotzampassi, K.(3);Kolios, G.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P068 Erythrocyte and reticulocyte parameters in children with inflammatory bowel diseases
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Semikina1, A. Potapov2, V. Tsvetkova2, A. Anoushenko2, S. Akulova1

Created: Thursday, 30 January 2020, 10:12 AM
P0680: Upadacitanib in Inflammatory Bowel Disease: Evaluating the risk of neutropenia and impact of thiopurine exposure
Year: 2025
Source: ECCO'25
Authors: Sharpex7x7x7 M.(1)*;Khosex7x7x7 S.(1);Fletcherx7x7x7 J.(1);Samantax7x7x7 S.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0681: Filgotinib for active Ulcerative Colitis in clinical practice - Effective treatment at week 8 is associated with higher clinical remission and persistence rates at Week 52 -
Year: 2025
Source: ECCO'25
Authors: Yamadax7x7x7 A.(1)*;Yokoyamax7x7x7 K.(1);Haradax7x7x7 Y.(1);Itox7x7x7 T.(1);Horiix7x7x7 T.(1);Kanazawax7x7x7 J.(1);Ikeharax7x7x7 H.(1);Kusanox7x7x7 C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0682: Effectivenessx7x7x7 safety and predictors of response to vedolizumab as first- or second-line biological therapy in patients with ulcerative colitis: A real-world observational multicenter study.
Year: 2025
Source: ECCO'25
Authors: Ferreirax7x7x7 S.(1)*;Serafim Parrax7x7x7 R.(2);Yukie Sassakix7x7x7 L.(3);Luz Parentex7x7x7 J.M.(4);Kurtz de Mellox7x7x7 M.(5);Andrade Cheblix7x7x7 L.(6);Luporinix7x7x7 R.L.(7);Tiburcio Alves Juniorx7x7x7 A.J.(8);Firmino Nóbregax7x7x7 F.J.(9);da Silvax7x7x7 B.C.(10);Mirandax7x7x7 E.F.(11);Botelho Quaresmax7x7x7 A.(12);Mattioli Nicollellix7x7x7 G.(13);Galhardi Gasparinix7x7x7 R.(14);de Medeiros Dutrax7x7x7 R.(3);da Conceição da Silvax7x7x7 K.(15);Oliveira Magro x7x7x7 D.(16);Imbrizix7x7x7 M.R.(16);Kibune Nagasako x7x7x7 C.(17);Féresx7x7x7 O.(18);de Almeida Tronconx7x7x7 L.E.(19);Kotzex7x7x7 P.G.(20);Fonseca Cheblix7x7x7 J.M.(21);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session